APA (7th ed.) Citation

AM, C., M, R., M, C., S, C., T, T., KK, S., . . . N, C. (2026). A prospective national precision medicine trial evaluating the feasibility of blood-based molecular profiling in patients with Cancer of Unknown Primary (CUP-COMP). British journal of cancer. https://doi.org/10.1038/s41416-026-03519-6

Chicago Style (17th ed.) Citation

AM, Conway, et al. "A Prospective National Precision Medicine Trial Evaluating the Feasibility of Blood-based Molecular Profiling in Patients with Cancer of Unknown Primary (CUP-COMP)." British Journal of Cancer 2026. https://doi.org/10.1038/s41416-026-03519-6.

MLA (9th ed.) Citation

AM, Conway, et al. "A Prospective National Precision Medicine Trial Evaluating the Feasibility of Blood-based Molecular Profiling in Patients with Cancer of Unknown Primary (CUP-COMP)." British Journal of Cancer, 2026, https://doi.org/10.1038/s41416-026-03519-6.